Jasper Therapeutics stock holds at USD 5.42 as pipeline data guide trading

Published on 09/23/2026 at 05:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Jasper Therapeutics stock closed at USD 5.42 on September 22, 2026, while its 52-week range was USD 3.61 to USD 8.95. The company reported USD 0 revenue in Q2 2026.

JSPR, US47191J1060, Illustration mit AI erstellt.

Jasper Therapeutics stock (ISIN US47191J1060) closed at USD 5.42 on Nasdaq on September 22, 2026, after changing 0.00 percent from the prior close. The stock's 52-week range was USD 3.61 to USD 8.95, giving investors a concrete measure of the distance between the latest quote and the recent high.

Pipeline value remains central

Jasper Therapeutics reported USD 0 revenue for the second quarter of 2026, reflecting the development-stage status of its business rather than a commercial sales base. The same period included a net loss of USD 0.32 per share, making clinical progress and financing capacity more important valuation inputs than sales growth.

The comparison with the prior-year quarter is material: the company had no product revenue in either period, so the central operating question is whether clinical milestones can change that profile. For investors, the absence of commercial revenue places greater weight on trial execution, regulatory progress and cash resources.

Losses shape the valuation

Jasper Therapeutics recorded a quarterly operating loss of USD 0.32 per share in Q2 2026. That figure is the key fundamental counterweight to the USD 5.42 share price on September 22, 2026, because the company remains dependent on development milestones rather than recurring revenue.

The stock's USD 8.95 52-week high was USD 3.53 above the September 22 close, while the USD 3.61 low was USD 1.81 below it. This range shows a wide trading spread around the current price and underlines the importance of dated clinical and financing updates in future price discovery.

Jasper Therapeutics stock stays data driven

Jasper Therapeutics stock closed at USD 5.42 on Nasdaq on September 22, 2026, with a daily change of 0.00 percent. The market capitalization and trading volume are dynamic market data points, while the latest reported quarterly loss and zero revenue provide the fundamental baseline for assessing the company.